Table 1.

Oncologic outcomes reported in systematic reviews of endoscopic treatment of UTUC with Ho:YAG or Nd:YAG laser ablation.

Authors	Year of publication	Follow-up time, mo	Upper tract recurrence rate, %	Bladder recurrence rate, %	Requiring RNU, %	CSS, %	OS, %	Renal salvage rate, %
Bader et al.[14]	2009	NR	14–44	25–36	NR	NR	NR	78–81
Adamis et al.[19]	2011	NR	29–74	35–40	NR	86–100	NR	78–81
Park and Jeon[8]	2013	20–53	25–90	15–53	0–28	82–100	45–100	NR
Verges et al.[7]	2017	19–73	23–90	43	17–36	47–100	NR	64–83
Petros et al.[9]	2018	24–58	65	44	0–33	70–100	35–100	NR

Values in the table were the ranges of values reported in the review articles.^{[7–9,14,19]}

CSS = cancer-specific survival; NR = not reported; OS = overall survival; RNU = radical nephroureterectomy; UTUC = upper tract urothelial carcinoma.